EP-4736896-A1 - BIOCOMPATIBLE DEVICE
Abstract
The present invention is a biocompatible device comprising an internal space configured to accommodate cells or tissues that secrete a biologically active substance, wherein the internal space is formed by disposing a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer in the device such that the semi-permeable membrane layer is on the outer side and the non-woven fabric layer is on the internal-space side, the semi-permeable membrane layer comprises a cellulose derivative laminated on a non-woven fabric using the non-woven fabric as a support, and the non-woven fabric layer comprises a thermoplastic non-woven fabric.
Inventors
- TSUDA Naoto
- NAKATSUKA SHUJI
Assignees
- Mochida Pharmaceutical Co., Ltd.
Dates
- Publication Date
- 20260506
- Application Date
- 20240628
Claims (13)
- A biocompatible device comprising an internal space configured to accommodate a cell or tissue that secretes a biologically active substance, wherein the internal space is formed by disposing a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer in the device such that the semi-permeable membrane layer is on an outer side and the non-woven fabric layer is on an internal-space side, the semi-permeable membrane layer comprises a cellulose derivative laminated on a non-woven fabric using the non-woven fabric as a support, and the non-woven fabric layer comprises a thermoplastic non-woven fabric.
- The device according to claim 1, having immunoisolatability.
- The device according to claim 1, wherein the cellulose derivative is cellulose acetate.
- The device according to claim 1, wherein the non-woven fabric comprises one or more resins selected from the group consisting of polyethylene, polypropylene, and polyethylene terephthalate.
- The device according to claim 1, wherein the internal space is formed by partial fusion of a surface of the non-woven fabric layer that is free of cellulose derivative.
- The device according to claim 1, wherein the cell that secretes a biologically active substance is an insulin-secreting cell or a pancreatic islet.
- The device according to claim 1, wherein the cell or tissue that secretes a biologically active substance is enclosed in the internal space with a hydrogel serving as a carrier.
- The device according to claim 1, wherein the composite membrane has a thickness of 10 to 1500 µm.
- The device according to any one of claims 1 to 8, for use in living-donor transplantation.
- A biocompatible composite membrane for producing the device according to any one of claims 1 to 8.
- A kit for living-donor transplantation, the kit comprising: a biocompatible device having an internal space formed by a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer; and a container including a cell or tissue that secretes a biologically active substance, wherein the kit is used in such a manner that the cell or tissue is enclosed in the internal space.
- A method of producing a biocompatible device, the method comprising a step of covering a hydrogel embedding a cell or tissue that secretes a biologically active substance with a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer, wherein, in the step, the semi-permeable membrane layer is disposed on an outer side and the non-woven fabric layer is disposed on a hydrogel side.
- A method of producing a biocompatible device, the method comprising a step of injecting a solution comprising a cell or tissue that secretes a biologically active substance and is mixed with a solution capable of hydrogelation into an internal space formed by a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer and gelling the solution capable of hydrogelation, wherein, in the step, the semi-permeable membrane layer is on an outer side and the non-woven fabric layer is on an internal-space side in the composite membrane.
Description
Technical Field The present invention relates to a biocompatible device for transplanting a cell or the like into a living body and a production method therefor, and a kit for living-donor transplantation. Background Art A therapeutic method of transplanting a cell or tissue into a living body is known as one of regenerative therapies for organs with functional disorder, and devices to be used for the therapy have been developed. For example, a technique of a bioartificial pancreas (BAP, also referred to as a bioartificial pancreatic islet), which includes a pancreatic islet covered with (encapsulated in) a polymeric gel, semi-permeable membrane, or the like that enables isolation from immunocytes and the like of a recipient and is permeable to nutritional components, insulin, and others, and is transplanted into a living body, has been examined as a device for treating type 1 diabetes mellitus for some time, and various devices for transplantation have been reported (Patent Literatures 1 to 4). In addition, biocompatible devices for transplantation that are used in therapeutic applications for a disease other than type 1 diabetes mellitus have been reported (Patent Literatures 5 to 7). An immunoisolation device with a membrane produced with polypropylene fiber and ethylene-vinyl alcohol copolymer has been reported (Patent Literature 8). Devices for transplantation with chemically cross-linked alginic acid have been reported (Patent Literatures 9, 10). Citation List Patent Literature Patent Literature 1: Japanese Translation of PCT International Application Publication No. 2022-502458Patent Literature 2: Japanese Patent Laid-Open No. 2019-097442Patent Literature 3: International Publication No. WO 2016/184872Patent Literature 4: Japanese Translation of PCT International Application Publication No. 2017-502008Patent Literature 5: Japanese Translation of PCT International Application Publication No. 2018-515582Patent Literature 6: Japanese Patent Laid-Open No. 2014-200199Patent Literature 7: Japanese Patent Laid-Open No. 2004-209228Patent Literature 8: International Publication No. WO 2022/092198Patent Literature 9: International Publication No. WO 2020/262642Patent Literature 10: International Publication No. WO 2022/137345 Summary of Invention Technical Problem In the circumstances as described above, a novel, practical biocompatible device or the like has been needed. Solution to Problem The present invention has the following features of (1) to (5). (1) The present invention enables production of a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer, wherein the semi-permeable membrane layer comprises a cellulose derivative laminated on a non-woven fabric using the non-woven fabric as a support, and the non-woven fabric layer comprises a thermoplastic non-woven fabric.(2) Use of the composite membrane enables enhancement of membrane strength in covering a hydrogel configured to accommodate a cell, tissue, or the like that secretes a biologically active substance.(3) The configuration in which the non-woven fabric surface of the composite membrane can be fused enables production of a device by heat sealing in a simple manner.(4) In transplanting a device produced with the composite membrane, improved adhesion rates in living bodies and improved cure rates in transplantation subjects are expected.(5) Disposing the non-woven fabric surface of the composite membrane on the inner side allows a hydrogel that is included in an internal space of the device and configured to accommodate a cell, tissue, or the like that secretes a biologically active substance to be fixed on the non-woven fabric surface of the composite membrane, preventing reduction in the survival rate of the cell or the like. More specifically, the present invention relates to: a biocompatible device comprising an internal space configured to accommodate a cell or tissue that secretes a biologically active substance, wherein the internal space is formed by disposing a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer in the device such that the semi-permeable membrane layer is on an outer side and the non-woven fabric layer is on an internal-space side, the semi-permeable membrane layer comprises a cellulose derivative laminated on a non-woven fabric using the non-woven fabric as a support, and the non-woven fabric layer comprises a thermoplastic non-woven fabric; a production method therefor; and others. Exemplary embodiments of the present invention are shown as [1-1] to [4A-3] in the following. [1-1] A biocompatible device having an internal space formed by a biocompatible composite membrane including a semi-permeable membrane layer and a non-woven fabric layer, wherein the semi-permeable membrane layer comprises a cellulose derivative formed on a non-woven fabric serving as a support and the non-woven fabric layer comprises the thermopla